(Q42537262)

1 November 2017

Structure based design: novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors (English)

1 reference

1 November 2017

Ghosh AK

1

1 reference

1 November 2017

Krishnan K

2

1 reference

1 November 2017

Walters DE

3

1 reference

1 November 2017

Cho W

4

1 reference

1 November 2017

Cho H

5

1 reference

1 November 2017

Koo Y

6

1 reference

1 November 2017

Trevino J

7

1 reference

1 November 2017

Holland L

8

1 reference

1 November 2017

Buthod J

9

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

Bioorganic & Medicinal Chemistry Letters

1 November 2017

1 reference

1 November 2017

8

1 reference

1 November 2017

8

1 reference

1 November 2017

979-982

1 reference

1 November 2017

The retroviral enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

The HIV-1 protease as a therapeutic target for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

Rational design of peptide-based HIV proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

CYCLIC SULFONE-3-CARBOXAMIDES AS NOVEL P-LIGANDS FOR Ro 31-8959 BASED HIV-1 PROTEASE INHIBITORS

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

Structure-based design of HIV-1 protease inhibitors: replacement of two amides and a 10 pi-aromatic system by a fused bis-tetrahydrofuran

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

The development of cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

Inhibitors of HIV-1 protease containing the novel and potent (R)-(hydroxyethyl)sulfonamide isostere

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

A simple, continuous fluorometric assay for HIV protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900139-5

7 January 2021

10.1016/S0960-894X(98)00139-5

Identifiers

DOI

1 reference

1 November 2017

1 reference